Imanol M. S.
- Country
- Spain
- Department
- Medical Oncology
Research Overview
- Efficacy of LY3537021 plus combination therapy versus placebo for chemotherapy-induced nausea and vomiting in adults with malignant disease
- Phase II Study of Sasanlimab and Sacituzumab Govitecan in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Patients
- A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of [177Lu]LU-PSMA-I&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
Data & Insights
Has run more than one trial at 218 of 405 partner sites.
Specializations
Prostate Cancer Research
The investigator specializes in treating metastatic castration-resistant prostate cancer (mCRPC), conducting research on innovative therapeutic approaches. Their work encompasses both early-stage disease management and advanced metastatic cases.
- Novel hormonal therapy combinations
- PSMA-targeted therapeutic approaches
- Diagnostic imaging techniques
Their expertise extends to evaluating treatment responses in prostate cancer patients using advanced imaging methodologies.
Bladder Cancer Expertise
The investigator focuses on comprehensive treatment approaches for urothelial carcinoma and non-muscle invasive bladder cancer (NMIBC). Their research encompasses various stages of disease progression.
- Immunotherapy combinations
- BCG therapy optimization
- Advanced therapeutic strategies
Their work includes investigating novel treatment combinations for both localized and metastatic disease states.
Advanced Solid Tumors
The investigator has extensive experience in treating various advanced solid tumors, with particular attention to targeted therapies and innovative treatment combinations.
- HER2-targeted therapies
- Multi-modal treatment approaches
- Novel therapeutic combinations
Their research includes evaluation of treatment responses across multiple cancer types using specialized assessment criteria.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.